Timing Optimization of Immunotherapy During Neoadjuvant Chemotherapy for Locally Advanced Nasopharyngeal Carcinoma

NCT07388836 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

198

Enrollment

OTHER_GOV

Sponsor class

Conditions

Locally Advanced Nasopharyngeal Carcinoma

Interventions

DRUG: Toripalimab
DRUG: Toripalimab

Sponsor

Fujian Cancer Hospital